Showing 5 of 45 recruiting trials for “Meningioma”
Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas
👨⚕️ Jean-Oliver ARNAUD, Director, Assistance Publique Hôpitaux de Marseille📍 1 site📅 Started Sep 2019View details ↗
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
👨⚕️ Jana Ivanidze, MD/Ph.D, Weill Medical College of Cornell University📍 1 site📅 Started Sep 2019View details ↗
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
👨⚕️ Priscilla Brastianos, MD, Massachusetts General Hospital📍 777 sites📅 Started Sep 2015View details ↗
← PreviousPage 3 of 3
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →